Cargando…

Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy

BACKGROUND: Red bone marrow (RBM) toxicity is dose-limiting in (pretargeted) radioimmunotherapy (RIT). Previous blood-based and two-dimensional (2D) image-based methods have failed to show a clear dose-response relationship. We developed a three-dimensional (3D) image-based RBM dosimetry approach us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woliner-van der Weg, Wietske, Schoffelen, Rafke, Hobbs, Robert F, Gotthardt, Martin, Goldenberg, David M, Sharkey, Robert M, Slump, Cornelis H, van der Graaf, Winette TA, Oyen, Wim JG, Boerman, Otto C, Sgouros, George, Visser, Eric P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545615/ https://www.ncbi.nlm.nih.gov/pubmed/26501807 http://dx.doi.org/10.1186/s40658-014-0104-x

Ejemplares similares

Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method
por: Schoffelen, Rafke, et al.
Publicado: (2012)

Pretargeted Molecular Imaging and Radioimmunotherapy
por: Goldenberg, David M., et al.
Publicado: (2012)

Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
por: Bodet-Milin, Caroline, et al.
Publicado: (2015)

A pretargeting system for tumor PET imaging and radioimmunotherapy
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
por: Schoffelen, R, et al.
Publicado: (2013)

Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin
por: van der Kroon, Inge, et al.
Publicado: (2017)

Harnessing (64)Cu/(67)Cu for a theranostic approach to pretargeted radioimmunotherapy
por: Keinänen, Outi, et al.
Publicado: (2020)

Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels–Alder Reaction and Key Factors in the Pretargeted Synthetic Design
por: Qiu, Lin, et al.
Publicado: (2019)

A 3D-printed anatomical pancreas and kidney phantom for optimizing SPECT/CT reconstruction settings in beta cell imaging using (111)In-exendin
por: Woliner-van der Weg, Wietske, et al.
Publicado: (2016)

Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study
por: Grana, C, et al.
Publicado: (2002)

Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin
por: de Jong, Gabie M., et al.
Publicado: (2009)

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT(R))
por: De Santis, R, et al.
Publicado: (2003)

Comparative Efficacy of (177)Lu and (90)Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models
por: Frost, Sofia H. L., et al.
Publicado: (2015)

Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
por: Rondon, Aurélie, et al.
Publicado: (2019)

A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer
por: Elekonawo, Fortuné M. K., et al.
Publicado: (2019)

A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats
por: Aarts, F., et al.
Publicado: (2007)

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012)

Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
por: Cheal, Sarah M., et al.
Publicado: (2018)

Therapeutic Applications of Pretargeting
por: Verhoeven, Marjolein, et al.
Publicado: (2019)

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
por: Quak, Elske, et al.
Publicado: (2015)

Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma
por: Calais, Phillipe J., et al.
Publicado: (2012)

Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches
por: van der Wal, Steffen, et al.
Publicado: (2018)

Pretargeted imaging beyond the blood–brain barrier
por: Shalgunov, Vladimir, et al.
Publicado: (2022)

Clearing and Masking Agents in Pretargeting Strategies
por: Staudt, Markus, et al.
Publicado: (2023)

Nuclear medicine imaging and therapy of neuroendocrine tumours
por: Gotthardt, Martin, et al.
Publicado: (2006)

Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling
por: Hobbs, R, et al.
Publicado: (2009)

Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
por: Magnani, P., et al.
Publicado: (1996)

Pretargeting for imaging and therapy in oncological nuclear medicine
por: Bailly, Clément, et al.
Publicado: (2017)

Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible?
por: Lopes van den Broek, Sara, et al.
Publicado: (2022)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms
por: van Dijk, B., et al.
Publicado: (2020)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Optimized labeling of NOTA-conjugated octreotide with F-18
por: Laverman, Peter, et al.
Publicado: (2011)

Rhenium‐186‐mercaptoacetyltriglycine‐labeled Monoclonal Antibody for Radioimmunotherapy: In vitro Assessment, in vivo Kinetics and Dosimetry in Tumor‐bearing Nude Mice
por: Kinuya, Seigo, et al.
Publicado: (1998)

Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models
por: Broqueza, Jaline, et al.
Publicado: (2021)

Characterization of Structurally Diverse (18)F-Labeled d-TCO Derivatives as a PET Probe for Bioorthogonal Pretargeted Imaging
por: Adhikari, Karuna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_en6amfrjttd7jaqomnab0s3dvi